See also this year's filing and all EDGAR filings for this company.
PDF Report 0001618561_2016_Nexvet_Biopharma_plc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001618561, Nexvet Biopharma plc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 55,941,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 19,000 |
| 2 | PropertyPlantAndEquipmentNet | 549,000 |
| 3 | remainder_Assets | 163,000 |
| 4 | LiabilitiesCurrent | 3,033,000 |
| 5 | LiabilitiesNoncurrent | 61,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,191,000 |
| 9 | ResearchAndDevelopmentExpense | 9,845,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 3,960,000 |
| 12 | remainder_NetIncome | 4,219,000 |
| 13 | remainder_ComprehensiveNetIncome | -4,920,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 56,672,000 |
| 1 | Liabilities | 3,094,000 |
| 2 | Expenses | 20,036,000 |
| 3 | Revenues | 3,960,000 |
| 4 | StockholdersEquity | 53,578,000 |
| 5 | NetIncome | -11,857,000 |
| 6 | ComprehensiveNetIncome | -14,317,000 |
| 7 | BaseVar | 46,450,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.43 |
| 9 | EconomicCapitalRatio | 3.98 |
Edgar->Model Mapping
Feature Distribution
Change over Time
